Statistics by Country for Immune Thrombocytopenic Purpura
|
About these extrapolations of prevalence and incidence statistics for Immune Thrombocytopenic Purpura:
These statistics are calculated extrapolations of various prevalence or incidence rates
against the populations of a particular country or region.
The statistics used for prevalence/incidence of Immune Thrombocytopenic Purpura are typically based on US, UK, Canadian or Australian statistics.
This extrapolation calculation is automated and does not take into account any genetic, cultural, environmental, social, racial or other differences
across the various countries and regions for which the extrapolated Immune Thrombocytopenic Purpura statistics below refer to.
As such, these extrapolations may be highly inaccurate (especially for developing or third-world countries) and only give a general indication (or even a meaningless indication)
as to the actual prevalence or incidence of Immune Thrombocytopenic Purpura in that region.
About prevalence and incidence statistics in general for Immune Thrombocytopenic Purpura: The word 'prevalence' of Immune Thrombocytopenic Purpura usually means the estimated population of people who are managing Immune Thrombocytopenic Purpura at any given time (i.e. people with Immune Thrombocytopenic Purpura). The term 'incidence' of Immune Thrombocytopenic Purpura means the annual diagnosis rate, or the number of new cases of Immune Thrombocytopenic Purpura diagnosed each year (i.e. getting Immune Thrombocytopenic Purpura). Hence, these two statistics types can differ: a short disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics. |
Prevalance of Immune Thrombocytopenic Purpura: rare.
Medical Tools & Articles:
Next articles:
Medical Articles: